# Americas Interventional Radiology Market

> Americas Interventional Radiology Market Research Report Information: by Type (MRI, Ultrasound imaging, CT scan, angiography), by Procedure (diagnostic, therapeutic), by Application (cardiology, oncology, urology & nephrology), by End User (hospitals, catheterization labs, and ambulatory surgical centers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.26%
- **2024:** $ 9.92 Billion
- **2025:** $ 10.5 Billion
- **2035:** $ 17.44 Billion
- **Key Players:** Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Siemens Healthineers (DE), Bayer (DE), Cook Medical (US), Terumo Corporation (JP), Philips (NL), Stryker Corporation (US)

**Report ID:** MRFR/MED/0409-HCR · **Pages:** 117 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/americas-interventional-radiology-market-914

---

## Market Summary

## **Americas Interventional Radiology Market Overview**

Americas Interventional Radiology Market Size was valued at USD 5.43 Billion in 2023. The Global Americas Interventional Radiology industry is projected to grow from USD 5.72 Billion in 2024 to USD 10.12 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.23% during the forecast period (2024 - 2032).

**Study Objectives:**

Main objective of this research is to provide information about interventional radiology market, type, procedure, application, and end user.

**Intended Audience**

**Market Scenario**

Interventional radiology is a sub specialty of radiology, which utilizes minimally invasive procedure for diagnosis and treatment of diseases. The aim of interventional radiology is to minimize the risk to patients and improve health outcomes.  Interventional radiologists perform both diagnostic and therapeutic procedures. MRI and CT scan are most widely used techniques in interventional radiology. The demand for minimally invasive procedures, extensive use of interventional radiology techniques, and increasing incidence of lifestyle diseases like obesity, heart diseases, and others boost the growth of this market in America.

The American market for Interventional radiology is expected to grow at a CAGR of about 5.12% during the forecast period 2017-2023.

## **Americas Interventional Radiology Market Segmentation**

Americas interventional radiology market has been segmented on the basis of types, procedure, application and end users. On the basis of types, the market is further segmented into MRI, Ultrasound imaging, CT scan, and angiography. On the basis of procedure, the market is segmented into diagnostic and therapeutic procedures. Diagnostic procedures include angiography, cholangiography, and biopsy. Therapeutic procedures include vascular, catheter placement, ablative, genitourinary, and pain management. On the basis of application, the market is segmented into cardiology, oncology, urology, nephrology, others. On the basis of by end user, it is segmented into hospitals, catheterization labs, and ambulatory surgical centers.

## **Americas Interventional Radiology Market Regional Analysis**

Americas interventional [radiology market](../../../reports/ai-in-radiology-market-21574) consists of North America and South America. North America accounts for the largest market share, and its growth is attributed to the presence of global market leaders, extensive use of interventional radiology, increasing the prevalence of chronic diseases such as diabetes, cancer, and other diseases. Furthermore, the prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures drive the growth of this market. Additionally, new products launch and technological advancements favor the growth of this market in America. However, fierce competition among major players may hamper entry of new participants in the market.

## **Americas Interventional Radiology Market Key Players**

The report for interventional radiology market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry.

The report also gives a broad study of the different markets segments and regions

## Market Drivers

### Rising Prevalence of Chronic Diseases

The North America [Interventional Radiology Products](https://www.marketresearchfuture.com/reports/interventional-radiology-products-market-11546) Market is experiencing growth due to the increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes. According to the Centers for Disease Control and Prevention, chronic diseases account for approximately 70% of all deaths in the United States. This alarming statistic drives the demand for advanced interventional radiology procedures, which are often less invasive and more effective than traditional surgical methods. As healthcare providers seek to improve patient outcomes, the adoption of interventional radiology products is likely to rise. Furthermore, the aging population in North America, which is more susceptible to these diseases, further fuels the market. The combination of these factors suggests a robust growth trajectory for the North America Interventional Radiology Products Market.

### Growing Preference for Outpatient Procedures

The North America Interventional Radiology Products Market is witnessing a shift towards outpatient procedures, driven by patient preferences and healthcare cost considerations. Patients increasingly favor minimally invasive procedures that allow for quicker recovery times and reduced hospital stays. According to a report from the American College of Radiology, outpatient interventional radiology procedures have seen a significant rise, with many patients opting for these alternatives to traditional surgeries. This trend not only enhances patient satisfaction but also reduces healthcare costs, making it an attractive option for providers. As more healthcare facilities adopt outpatient models, the demand for interventional radiology products is likely to grow. This shift towards outpatient care is indicative of a broader transformation in the North America Interventional Radiology Products Market, emphasizing efficiency and patient-centered care.

### Regulatory Support for Innovative Treatments

Regulatory support for innovative treatments is a key driver of the North America Interventional Radiology Products Market. Agencies such as the Food and Drug Administration (FDA) are actively promoting the development and approval of new interventional radiology products that demonstrate safety and efficacy. The FDA's expedited review processes for breakthrough devices facilitate quicker access to advanced technologies for healthcare providers and patients. This regulatory environment encourages innovation and investment in the interventional radiology sector, as companies are more likely to pursue research and development of novel products. As regulatory frameworks continue to evolve in favor of innovation, the North America Interventional Radiology Products Market is poised for growth, with an increasing array of products entering the market to meet the demands of healthcare providers.

### Technological Innovations in Imaging Techniques

Technological advancements in imaging techniques are significantly influencing the North America Interventional Radiology Products Market. Innovations such as 3D imaging, MRI-guided interventions, and advanced ultrasound technologies enhance the precision and effectiveness of interventional procedures. These technologies not only improve diagnostic accuracy but also facilitate real-time monitoring during procedures, thereby reducing complications and enhancing patient safety. The integration of artificial intelligence in imaging is also emerging, potentially streamlining workflows and improving decision-making processes for healthcare professionals. As hospitals and clinics invest in state-of-the-art imaging technologies, the demand for interventional radiology products is expected to increase. This trend indicates a promising future for the North America Interventional Radiology Products Market, as healthcare providers strive to adopt the latest innovations to improve patient care.

### Increased Investment in Healthcare Infrastructure

The North America Interventional Radiology Products Market is benefiting from increased investment in healthcare infrastructure. Governments and private entities are allocating substantial funds to enhance healthcare facilities, particularly in the realm of advanced medical technologies. This investment is crucial for the development and expansion of interventional radiology services, as it enables hospitals to acquire the latest equipment and technologies necessary for effective patient care. For instance, the U.S. government has implemented various initiatives aimed at improving healthcare access and quality, which indirectly supports the growth of interventional radiology. As healthcare infrastructure continues to evolve, the demand for interventional radiology products is expected to rise, reflecting the industry's adaptability to changing healthcare landscapes. This trend underscores the potential for sustained growth within the North America Interventional Radiology Products Market.

## Future Outlook

The North America Interventional Radiology Products Market is projected to grow at a 5.26% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of chronic diseases, and rising demand for minimally invasive procedures.

**New opportunities:**

- Development of AI-driven imaging solutions for enhanced diagnostic accuracy.
- Expansion of telehealth services for remote interventional radiology consultations.
- Investment in biodegradable stents to meet sustainability goals in healthcare.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in innovative healthcare solutions.

## Segment Insights

### By Application: Oncology (Largest) vs. Urology (Fastest-Growing)

In the North America Interventional Radiology Products Market, Oncology emerges as the dominant segment, holding a significant share due to the rising prevalence of cancer and the increasing adoption of minimally invasive procedures. Urology closely follows, witnessing rapid growth as advancements in technology and an aging population drive demand for interventional radiology solutions in urinary issues. As healthcare providers focus on improving patient outcomes, these segments are expected to shape the market dynamics significantly.

Oncology: Dominant vs. Urology: Emerging

Oncology, as the dominant segment, leverages sophisticated imaging techniques, allowing for precise tumor targeting and enhanced treatment efficacy. This segment benefits from the increasing number of cancer cases and escalating awareness regarding early diagnosis. Urology represents an emerging segment, fueled by technological innovations that enable less invasive procedures, thereby improving patient comfort and recovery times. The growing incidence of urological disorders, coupled with robust research and development efforts, positions Urology for substantial growth and increased market penetration, benefiting from the cross-specialty application of interventional radiology.

### By Product Type: Catheters (Largest) vs. Guidewires (Fastest-Growing)

In the North America Interventional Radiology Products Market, catheters hold the largest market share among product types, significantly influencing procedural outcomes and patient care. Following catheters, guidewires are gaining traction based on their essential role in successfully navigating complex vascular pathways during minimally invasive procedures. Other product types, such as embolization devices, ablation devices, and stents, also play crucial roles but are generally smaller in terms of market share.

Catheters (Dominant) vs. Guidewires (Emerging)

Catheters dominate the North America Interventional Radiology Products Market due to their extensive application in diagnostic and therapeutic procedures. They are engineered for optimal flexibility and maneuverability, enabling clinicians to achieve precise placements in challenging anatomies. Meanwhile, guidewires, considered an emerging product, are experiencing rapid growth as they are pivotal in various interventional techniques, particularly in enhancing the access and delivery of other devices. The evolution in design and materials, along with advancements in imaging techniques, is significantly boosting their adoption rates.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the North America Interventional Radiology Products Market, hospitals hold the largest share, benefiting from extensive patient throughput and comprehensive medical services. This segment is bolstered by sophisticated infrastructure and a wide range of interventional procedures. In contrast, ambulatory surgical centers are rapidly gaining ground, responding to the increasing demand for outpatient services and cost-effective procedures.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

The hospitals segment is characterized by a well-established infrastructure, facilitating advanced interventional radiology procedures with a broad array of technologies. Their dominance is attributed to higher patient volumes and access to a variety of specialists. On the other hand, ambulatory surgical centers are emerging as significant players, driven by the trend towards outpatient care. These centers focus on specific procedures and provide patients with a streamlined experience, leading to shorter recovery times and reduced healthcare costs. This growth reflects changing patient preferences towards less invasive procedures and better healthcare efficiency.

### By Procedure Type: Ablation (Largest) vs. Embolization (Fastest-Growing)

In the North America Interventional Radiology Products Market, the distribution of procedure types showcases a diverse landscape. Ablation leads as the largest segment, driven by increasing adoption in cancer treatment and various cardiovascular conditions. Following closely are biopsy and vascular intervention segments, representing significant shares due to their routine applications in diagnostic procedures and vascular disease management. Drainage and embolization, while not as dominant, contribute notably to the overall market dynamics.
The growth trends reveal that embolization is the fastest-growing procedure type, spurred by advancements in technology and increased procedural volume. Factors such as the rising prevalence of liver and kidney diseases, along with greater awareness and diagnosis capabilities for cancer, encourage a shift towards minimally invasive techniques, positioning embolization for rapid growth. Overall, the interplay among these procedure types illustrates a robust and evolving market landscape focused on enhanced patient care.

Ablation (Dominant) vs. Embolization (Emerging)

Ablation stands out as the dominant procedure type in the North America Interventional Radiology Products Market, primarily due to its established role in treating tumors and cardiovascular issues. This segment benefits from extensive clinical support and robust technology, making it a preferred choice among healthcare professionals. Meanwhile, embolization is emerging rapidly, characterized by innovative techniques and the ability to treat a wide range of conditions effectively. This segment is gaining traction with advancements in catheter technologies and an increasing number of clinical applications. The growing demand for minimally invasive surgery underscores embolization's potential to reshape interventional radiology, complementing the long-standing prominence of ablation in the healthcare sector.

### By Technology: Fluoroscopy (Largest) vs. Ultrasound (Fastest-Growing)

In the North America Interventional Radiology Products Market, Fluoroscopy currently holds the largest market share among the various technologies employed in this field. Following closely, Ultrasound is gaining significant traction as a preferred imaging modality, particularly in outpatient settings and in patient-friendly environments. Other technologies like CT and MRI imaging continue to contribute to overall market dynamics but don't match the leading positions of Fluoroscopy and Ultrasound.
Market trends indicate a growing preference for less invasive techniques, which is driving the uptake of imaging technologies such as Ultrasound. Factors such as technological advancements, improved imaging quality, and an increase in the prevalence of chronic diseases bolster the expansion of this segment. Additionally, the rising focus on patient safety and lower radiation exposure further favor the growth of these modalities in interventional radiology.

Fluoroscopy: Dominant vs. Ultrasound: Emerging

Fluoroscopy remains the dominant technology in the North America Interventional Radiology Products Market due to its ability to provide real-time imaging, which is crucial for various interventional procedures. It allows for the visualization of internal structures during minimally invasive surgeries, making it indispensable in clinical practices. Conversely, Ultrasound is emerging as a preferred alternative, especially in non-invasive settings, as it offers enhanced safety and greater patient comfort. The technology has seen rapid advancements, leading to better image clarity and diagnostic capabilities. Consequently, while Fluoroscopy is established in interventional use, Ultrasound is carving out a valuable position, particularly in early diagnosis and routine check-ups.

## Regional Market Share Analysis

### US : Innovative Technologies Drive Growth

The US holds a commanding market share of 8.12% in the Interventional Radiology Products Market, valued at approximately $8 billion. Key growth drivers include advancements in minimally invasive procedures, increasing prevalence of chronic diseases, and a robust healthcare infrastructure. Regulatory support from agencies like the FDA and government initiatives aimed at improving healthcare access further bolster demand. The rise in outpatient procedures and technological innovations are shaping consumption patterns favorably.

### Canada : Regulatory Support Fuels Development

Canada's Interventional Radiology Products Market accounts for 1.8% of the North American share, valued at around $1.8 billion. Growth is driven by increasing investments in healthcare technology, a rising aging population, and supportive regulatory frameworks. The Canadian government is actively promoting healthcare innovation, which is reflected in the growing demand for advanced radiology products. Infrastructure improvements in urban centers are also enhancing service delivery.

## Competitive Benchmarking

The Interventional Radiology Products Market in North America is characterized by a dynamic competitive landscape, driven by technological advancements, increasing demand for minimally invasive procedures, and a growing aging population. Key players such as Medtronic (US), Boston Scientific (US), and Johnson & Johnson (US) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous research and development, while Boston Scientific (US) emphasizes strategic partnerships to bolster its technological capabilities. Johnson & Johnson (US) adopts a multifaceted approach, integrating digital transformation into its operations to improve patient outcomes and streamline processes. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and patient-centric solutions.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to the specific needs of healthcare providers and patients alike. The collective influence of these companies shapes the market dynamics, fostering an environment where innovation and quality are paramount.

In December 2025, Medtronic (US) announced the launch of its latest imaging technology designed to improve the accuracy of interventional procedures. This strategic move is significant as it not only enhances Medtronic's product offerings but also positions the company as a leader in the integration of advanced imaging solutions within interventional radiology. Such innovations are likely to attract healthcare providers seeking to improve procedural outcomes.

In November 2025, Boston Scientific (US) entered into a partnership with a leading AI technology firm to develop predictive analytics tools for interventional radiology. This collaboration is indicative of the growing trend towards digitalization in healthcare, suggesting that Boston Scientific is keen on harnessing AI to enhance decision-making processes in clinical settings. The implications of this partnership could lead to improved patient management and operational efficiencies.

In October 2025, Johnson & Johnson (US) expanded its product line by acquiring a smaller firm specializing in advanced catheter technologies. This acquisition is strategically important as it not only diversifies Johnson & Johnson's offerings but also strengthens its competitive position in the market. The integration of these advanced technologies is expected to enhance the company's capabilities in delivering innovative solutions to healthcare providers.

As of January 2026, current competitive trends in the Interventional Radiology Products Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve, shifting from price-based competition to a focus on technological advancements, innovation, and supply chain reliability. This transition underscores the importance of delivering high-quality, efficient solutions that meet the evolving needs of the healthcare sector.

## Report Scope

| MARKET SIZE 2024 | 9.92(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 10.5(USD Billion) |
| MARKET SIZE 2035 | 17.44(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.26% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), Siemens Healthineers (DE), Bayer (DE), Cook Medical (US), Terumo Corporation (JP), Philips (NL), Stryker Corporation (US) |
| Segments Covered | Application, Product Type, End User, Procedure Type, Technology |
| Key Market Opportunities | Advancements in minimally invasive techniques drive growth in the North America Interventional Radiology Products Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in North America's Interventional Radiology Products Market. |
| Countries Covered | US, Canada |

## Frequently Asked Questions

**Q: What is the projected market valuation of the North America Interventional Radiology Products Market by 2035?**
A: The market is projected to reach a valuation of 17.44 USD Billion by 2035.

**Q: What was the market valuation of the North America Interventional Radiology Products Market in 2024?**
A: The market valuation was 9.92 USD Billion in 2024.

**Q: What is the expected CAGR for the North America Interventional Radiology Products Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 5.26%.

**Q: Which application segment is projected to have the highest growth in the North America Interventional Radiology Products Market?**
A: The Oncology segment is projected to grow from 2.5 USD Billion in 2024 to 4.4 USD Billion by 2035.

**Q: What are the key product types in the North America Interventional Radiology Products Market?**
A: Key product types include Catheters, Guidewires, Embolization Devices, Ablation Devices, and Stents.

**Q: Which end user segment is expected to dominate the North America Interventional Radiology Products Market by 2035?**
A: Hospitals are expected to dominate, growing from 3.96 USD Billion in 2024 to 6.93 USD Billion by 2035.

**Q: What is the projected growth for the Ablation procedure type in the North America Interventional Radiology Products Market?**
A: The Ablation procedure type is projected to grow from 2.48 USD Billion in 2024 to 4.34 USD Billion by 2035.

**Q: Who are the leading companies in the North America Interventional Radiology Products Market?**
A: Key players include Medtronic, Boston Scientific, Johnson & Johnson, Siemens Healthineers, and Bayer.

**Q: What technology segment is anticipated to see substantial growth in the North America Interventional Radiology Products Market?**
A: CT Imaging is anticipated to grow from 2.5 USD Billion in 2024 to 4.0 USD Billion by 2035.

**Q: How does the North America Interventional Radiology Products Market compare to other regions?**
A: While specific regional comparisons are not provided, the North America market is characterized by robust growth and significant investments from leading companies.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/americas-interventional-radiology-market-914*